This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI HUMAN ANGIOGENIN
catalog :
0555-5008
quantity :
0.15 mg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
MANG-1
reactivity :
human
product information
Entity Category :
Antibodies
Product Code :
0555-5008
Description :
MOUSE ANTI HUMAN ANGIOGENIN
Specificity :
ANGIOGENIN
Target Species :
Human
Host :
Mouse
Format :
S/N
Isotypes :
IgM
Applications :
C, E, P*
Application Types :
Immunohistology - Paraffin, Immunohistology - Frozen, ELISA
Clone :
MANG-1
Quantity :
0.15 mg
Quantity Value :
0.15 mg
Quantity Type :
mg
GO Accessions :
GO:0001525, GO:0001541, GO:0001556, GO:0001666, GO:0001890, GO:0001938, GO:0003677, GO:0003779, GO:0005102, GO:0004522, GO:0005507, GO:0005605, GO:0005615, GO:0005730, GO:0006651, GO:0007154, GO:0007202, GO:0008201, GO:0008219, GO:0030041, GO:0009303, GO:0009725, GO:0016477, GO:0017148, GO:0019843, GO:0030426, GO:0032148, GO:0032311, GO:0032431, GO:0042277, GO:0042327, GO:0042592, GO:0043025, GO:0048662, GO:0050714
GO Terms :
actin polymerization, actin polymerizing activity, activation of endothelial cell proliferation, activation of phosphorylation, activation of protein secretion, alkaline ribonuclease activity, angiogenin-placental ribonuclease inhibitor complex, basement lamina, blood vessel formation from pre-existing blood vessels, ceratitis capitata alkaline ribonuclease activity, copper binding, copper/cadmium binding, diacylglycerol anabolism, diacylglycerol biosynthesis, diacylglycerol formation, diacylglycerol synthesis, down regulation of protein biosynthetic process, down regulation of smooth muscle cell proliferation, downregulation of protein biosynthetic process, down-regulation of protein biosynthetic process, downregulation of smooth muscle cell proliferation, down-regulation of smooth muscle cell proliferation, endoribonuclease I, follicular phase, gene S glycoproteins, gene S locus-specific glycoproteins, GO:0016478, growth regulator, heparan sulfate binding, homeostasis, inhibition of protein biosynthetic process, inhibition of smooth muscle cell proliferation, intercellular space, membrane associated actin binding, microtubule/chromatin interaction, necrosis, negative regulation of protein anabolism, negative regulation of protein biosynthesis, negative regulation of protein biosynthetic process, negative regulation of protein formation, negative regulation of protein synthesis, negative regulation of SMC proliferation, neuron cell body, neuronal cell soma, pancreatic RNase activity, phospholipase A2 activation, phospholipase C activation, placental development, placentation, plasmid binding, protein biosynthesis inhibitor activity, protein biosynthetic process inhibitor activity, protein kinase B activation, receptor ligand, receptor-associated protein activity, response to hypoxic stress, response to lowered oxygen tension, ribonuclease A, ribonuclease I activity, ribonucleate 3'-pyrimidino-oligonucleotidohydrolase activity, ribonucleic phosphatase activity, RNase A activity, RNase activity, RNase I activity, rRNA biosynthesis, rRNA biosynthetic process, rRNA synthesis, S-genotype-assocd. glycoproteins, SLSG glycoproteins, stimulation of endothelial cell proliferation, stimulation of phosphorylation, stimulation of protein secretion, up regulation of endothelial cell proliferation, up regulation of phosphorylation, up regulation of protein secretion, upregulation of endothelial cell proliferation, up-regulation of endothelial cell proliferation, upregulation of phosphorylation, up-regulation of phosphorylation, upregulation of protein secretion, up-regulation of protein secretion
Uniprot Accessions :
P03950
Gene :
ANG
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=283
EntityFormats :
S/N
UNSPSC :
41116161
Concentration :
IgM concentration 0.3 mg/ml
Product Form :
Tissue Culture Supernatant - lyophilised
PrimarySecondary :
Primary
company information

Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments